We are Sorry, This Page doesn't Exist
J&J"s single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection
J&J's shot was more effective among volunteers in the US than in Latin America and South Africa, where new strains are circulating. A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccin.....»»
Spring Bank drops 9% to $3.30 after halting Phase 2b inarigivir trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Science hinted that cancer patients could take less of a $148,000-a-year drug. Its maker tripled its price.
Just as scientific momentum was building to test the effectiveness of lower doses, the new pricing scheme ensured dose reductions wouldn't save patients money or erode companies' revenue......»»
The Navy"s new, powerful aircraft carrier is heading to "shock trials"
Before the supercarrier ties up in Newport News this summer, it will go through full-ship shock trials to test how it handles nearby explosions. US Navy aircraft ca.....»»
Protagonist Therapeutics announces first subject dose in phase 1 study of PN-232
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Coronavirus links: becoming endemic
A coronavirus pandemic linkfest is for now a weekly feature here on Abnormal Returns. Please stay safe and find a vaccination site... VaccinesThe Sanofi-GSK vaccine is entering Phase 3 trials. (statnews.com)There .....»»
Merck: V114 met primary endpoints in two trials of Phase 3 pediatric program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant Sciences drops after FDA places partial clinical hold on Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mustang Bio, City of Hope dose first patient in Phase 1 trial of MB-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arcutis Biotherapeutics presents new data from DERMIS-1, DERMIS-2 phase 3 trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Genetic to present data from XLRP, Achromatopsia phase 1/2 trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
More Signs Of Slowing US Vaccine Demand Emerge As Some States Turn Down Shipments
More Signs Of Slowing US Vaccine Demand Emerge As Some States Turn Down Shipments As a surprising number of Americans (mostly millennials who face lower risks) miss their second COVID-19 vaccine dose, the Wall Street Journal has become the la.....»»
Abbott"s stock drops 3%, though earnings more than tripled for the medical test company in the first quarter
Shares of Abbott Laboratories were down 3.2% in premarket tr.....»»
QuantumScape drops 15% after short-seller report calls it a "pump-and-dump SPAC scam by Silicon Valley celebrities" and compares it to disgraced startup Theranos
QuantumScape is developing a scalable solid-state battery that would improve charging times, extend driving range, and lower costs for electric cars. Drew Angerer/Getty Images QuantumScape fell as much as 15% on Thursday after short-seller .....»»
Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clene to release results from four Phase 2 trials in 2H, says Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect
Immunic Inc’s (NASDAQ: IMUX) lead candidate, IMU-838, has an “attractive safety profile” and exhibited positive efficacy results in the Phase II trials, according to JMP Securities. read more.....»»
Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ideaya announces dose expansion of Phase 1/2 study of IDE196/binimetinib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»